UAE. US-based medical practice targets UAE with breakthrough genetic-based programmes
DUBAI (United Arab Emirates): With chronic medical illnesses such as heart disease and hypertension being among the top causes of death in the UAE, health experts are now concerned that the residents’ cosmopolitan lifestyle is taking its toll on their health and will need to undergo a dramatic paradigm shift in order to prevent further rise in the number of lives taken by chronic diseases.

In light of this, US-based Cenigent Health Enhancement Medical Institute has unveiled the world’s first medical programme that is founded on a new “systems and genetic-based” medical approach.

Cenigent's programme presents UAE residents, who have a high average life expectancy of 77 years, the opportunity to avoid age-related chronic disease and enjoy their later years in life via a groundbreaking method that recognises the dynamics of the human body’s complex systems and their relationships to health and disease.

Cenigent's systems approach differs tremendously from the current modern “reductionist” medical approach, which focuses on treating the end-symptoms of disease, rather than the core causes, and according to the Journal of the American Medical Association (JAMA), “treats disease in isolation, without taking into account the integrative systems in the human body.”

Recent studies show that one in four Emiratis has diabetes in contrast with the world average of 5%. The World Health Organisation has also predicted that diabetes deaths will increase by more than 50% in the next 10 years if no preventive measures are taken. Meanwhile, osteoporosis, a bone-weakening disorder, affects 70% of women over 60 in the GCC.

But even with the higher prevalence of these diseases, fewer residents are interested in tackling these life-threatening conditions, with 42% of women putting staying slim as their top health concern.

Such widespread occurrence of chronic illnesses and ignorance of vital health issues among UAE residents has caused authorities to urge people to seize every available opportunity to live a healthier lifestyle.

As the first and only medical facility using a systems approach in a clinical setting, California-headquartered CENIGENT delineates itself from modern medicine’s philosophy that aging and age-related chronic diseases inevitably occur and should be accepted.

Cenigent’s view is that age-related health decline occurs due to functional deterioration of the eight Cenigent systems and can be prevented by restoring the optimal functioning to all eight systems.
To achieve this, Centigent follows a systems approach, performing predictive testing and assessments followed by restorative measures to optimise the major systems, avert age-related health decline and achieve peak health. CENIGENT conducts comprehensive predictive and preventive diagnostics for more than 750 biomarkers, as well as screening and total body imaging diagnostics, to assess all aspects of existing and potential health decline.

Building the First Systems and Genetic-Based Medical Practice
Cenigent systems approach recognises the body as a complex system and has classified eight core sub-systems and their relationships to health and disease.  When there is a dysfunction in any of these core systems, it can lead to age-related chronic disease.

C – Cellular System E – Endocrine System N – Nervous System I – Immune System
G – Genetic System E – Epigenetic System N – Nutrigenomics T – Thought System

These subsystems and their relationships are the common links for many age-related chronic diseases including cardiovascular, Alzheimer’s, Parkinson’s, diabetes, obesity, osteoarthritis, rheumatoid arthritis and others.  Cenigent exhaustively evaluates and optimizes these sub-systems to predict, prevent and treat disease,” said Lida Ghaderi, M.D., founder and medical director of Cenigent, a noted internist with expertise in the new field of personalised genetics.

“Cenigent uses the information from personalised genetic testing differently than simply assigning risks for diseases. We use proprietary genetic software and exhaustive research on these results to recommend personalised treatment programmes, translating to better prevention and treatment of disease. We also accommodate Islamic religious laws, such as offering Halal meals and the necessary prayer items, and make sure our treatments are Halal as well,” she added.
Support from the medical community

Due to their innovation, Cenigent’s programmes have garnered extensive support from the medical community in the United States.

Joseph Wu, M.D., clinical director of the University of California, Irvine Brain Imaging Center and associate professor in residence at the UCI Department of Psychiatry and Human Behavior, said, “CENIGENT is innovative and incorporates the latest biomedical and genetic research (translational and personalised medicine) to provide state-of-the-art assessment and treatment recommendations. The CENIGENT approach is the future of medicine.”

MIDDLE EAST BUSINESS COMMENT & ANALYSIS

• Top news
• Business News
• Company News